- July 17, 2025
- July 17, 2025
Study Finds Higher BMI Increases Breast Cancer Risk in Women With Heart Conditions
Research reveals that higher BMI in women with cardiovascular disease significantly increases breast cancer risk, highlighting the need for targeted…
- July 17, 2025
FDA Approves Zoster Vaccine Recombinant Prefilled Syringe Presentation for Shingles Prevention
The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50…
- July 17, 2025
Gabapentin Use Linked to Increased Dementia Risk in Chronic Back Pain Patients
New research links gabapentin use for back pain to increased dementia risk, especially in non-elderly adults.
- July 17, 2025
1044: Converting inpatients from insulin glargine 300 units/mL to insulin detemir 100 units/mL without causing hypoglycemia
Show notes at pharmacyjoe.com/episode1044. In this episode, I’ll discuss converting inpatients from insulin glargine 300 units/mL to insulin detemir 100…
- July 16, 2025
GLP-1 and GIP Combination Shows Promise for Weight Loss, Cardiometabolic Improvement in Obesity
Maridebart cafraglutide showed promising results for weight management in obesity and type 2 diabetes (T2D), achieving significant weight loss without…
- July 16, 2025
Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?
Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.
- July 16, 2025
Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback
New research shows effective interventions can reduce prescriptions across all ages.
- July 16, 2025
Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis
An adjusted analysis of the ALPINE and ASCEND trials revealed a statistically significant progression-free survival advantage for Zanubrutinib.